Staley Capital Advisers Inc. Sells 25,000 Shares of Option Care Health, Inc. $OPCH

Staley Capital Advisers Inc. trimmed its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 11.1% in the first quarter, Holdings Channel.com reports. The firm owned 200,000 shares of the company’s stock after selling 25,000 shares during the quarter. Staley Capital Advisers Inc.’s holdings in Option Care Health were worth $5,384,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. V Square Quantitative Management LLC bought a new stake in shares of Option Care Health during the fourth quarter worth $25,000. Advisory Services Network LLC acquired a new position in shares of Option Care Health during the third quarter worth $35,000. McIlrath & Eck LLC bought a new position in shares of Option Care Health in the 2nd quarter valued at $37,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Option Care Health in the 3rd quarter valued at $38,000. Finally, Quarry LP boosted its holdings in shares of Option Care Health by 502.7% during the 3rd quarter. Quarry LP now owns 1,549 shares of the company’s stock valued at $43,000 after acquiring an additional 1,292 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Down 0.5%

Shares of NASDAQ:OPCH opened at $21.47 on Thursday. The firm has a market cap of $3.37 billion, a P/E ratio of 16.64, a P/E/G ratio of 1.20 and a beta of 0.65. Option Care Health, Inc. has a 12-month low of $18.01 and a 12-month high of $36.80. The business has a fifty day simple moving average of $21.26 and a 200 day simple moving average of $27.99. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.03. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business’s revenue was up 1.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Analysts predict that Option Care Health, Inc. will post 1.64 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO John Charles Rademacher acquired 12,500 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were bought at an average cost of $21.18 per share, with a total value of $264,750.00. Following the completion of the purchase, the chief executive officer directly owned 695,152 shares in the company, valued at $14,723,319.36. The trade was a 1.83% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, Director Timothy P. Sullivan bought 24,154 shares of Option Care Health stock in a transaction that occurred on Thursday, May 7th. The stock was bought at an average price of $20.69 per share, for a total transaction of $499,746.26. Following the completion of the acquisition, the director directly owned 73,383 shares of the company’s stock, valued at $1,518,294.27. The trade was a 49.06% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 73,264 shares of company stock valued at $1,548,316 over the last ninety days. 1.70% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on OPCH. Barrington Research reduced their price objective on Option Care Health from $42.00 to $32.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. JPMorgan Chase & Co. dropped their target price on Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a research report on Monday, May 4th. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price target on the stock. in a research note on Friday, May 1st. Stephens set a $30.00 price target on Option Care Health in a report on Friday, May 1st. Finally, Morgan Stanley set a $28.00 price objective on Option Care Health in a research note on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Option Care Health currently has an average rating of “Moderate Buy” and a consensus target price of $30.54.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.